Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $12.10
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Sep 15, 26 |
Daily · Wilder smoothing
| DA Davidson |
| maintain |
| Buy |
| Buy |
| Aug 14, 26 | Lake Street | maintain | Buy | Buy |
| Aug 14, 26 | JP Morgan | maintain | Overweight | Overweight |
| Aug 14, 26 | DA Davidson | maintain | Buy | Buy |
| Aug 14, 26 | Needham | maintain | Buy | Buy |
| Aug 6, 26 | DA Davidson | maintain | Buy | Buy |
| May 15, 26 | Needham | maintain | Buy | Buy |
| Feb 12, 26 | Needham | maintain | Buy | Buy |
| Nov 13, 25 | B of A Securities | maintain | Buy | Buy |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 59.79 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 94.28 | Oscillator | Sell |
| Williams %R (14) | -5.33 | Oscillator | Sell |
| MACD (12, 26, 9) | 0.00 (Hist 0.12) | Oscillator | Strong Buy |
| Average Directional Index (14) | 19.54 (+DI 25.1 / -DI 18.2) | Trend | Neutral |
| EMA 20 | 11.43 | MA | Strong Buy |
| SMA 20 | 11.29 | MA | Strong Buy |
| EMA 50 | 11.82 | MA | Buy |
| SMA 50 | 11.39 | MA | Strong Buy |
| SMA 200 | 13.55 | MA | Strong Sell |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 16, 26 | Barter David | officer: Chief Financial Officer | S-Sale | 12,134 @ $11.21 | $136.1K |
| Sep 17, 26 | Utsumi Ryusuke | director | A-Award | 15,190 | — |
| Sep 17, 26 | Domnitz Yonatan | director | A-Award | 15,190 | — |
| Sep 17, 26 | Clammer Adam | director | A-Award | 15,190 | — |
| Sep 24, 26 | Ramji Shiven | director, officer: Chief Executive Officer | A-Award | 38,505 | — |
| Sep 17, 26 | Van Buren Brandon | director | A-Award | 15,190 | — |
| Sep 17, 26 | Richardson Troy | director | A-Award | 15,190 | — |
| Sep 17, 26 | Gruber Dafna | director | A-Award | 15,190 | — |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
TTM vs. 5-year historical average (annual ratios)
| Metric | CLBT | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 51.4x | 8.9x · sector 44.2x | Elevated |
| Forward P/E (FY26E) | 43.9x | EPS est. 0.28 | In line |
| Price / Book | 5.6x | 13.2x | Discount |
| Price / Sales | 5.9x | 6.7x | In line |
| EV / EBITDA | 25.7x | 4.1x | Elevated |
| Return on equity | 11.9% | — | Healthy |
| Gross margin | 83.0% | 83.2% | In line |
| Debt / Equity | 0.04 | 0.14 | Conservative |
| Piotroski / Altman Z | 4/9 | Z 4.99 | Safe zone |
Discounted cash flow model
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 19, 2026 | 2026-10-19 06:56:11 | View |
| SC 13G | Oct 9, 2026 | 2026-10-09 18:56:01 | View |
| 4 | Sep 29, 2026 | 2026-09-29 20:40:39 | View |
| 4 | Sep 29, 2026 | 2026-09-29 20:05:48 | View |
| 4 | Sep 28, 2026 | 2026-09-28 16:15:45 | View |
| 4 | Sep 25, 2026 | 2026-09-25 16:05:37 | View |
| 6-K | Sep 24, 2026 | 2026-09-24 16:01:25 | View |
| 4 | Sep 17, 2026 | 2026-09-17 08:53:21 | View |
| 4 | Sep 17, 2026 | 2026-09-17 08:08:01 | View |
| 4 | Sep 17, 2026 | 2026-09-17 08:06:33 | View |
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Investigators report dramatic gains in what they uncover using Agentic AI vs. manual review; the Autumn 2026 Release brings expanded device and operating system access TYSONS CORNER, Va.
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (NASDAQ: CLBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | 0.06 | 0.03 | Miss -56.7% | $131.1M |
| May 14, 2026 | 0.05 | 0.04 | Miss -25.6% | $128.3M |
| Feb 11, 2026 | 0.14 | 0.09 | Miss -38.1% | $128.8M |
| Nov 12, 2025 | 0.09 | 0.08 | Miss -15.3% | $126.0M |
| Aug 14, 2025 | 0.10 | 0.12 | Beat 20.0% | $113.3M |
| May 14, 2025 | 0.05 | 0.10 | Beat 90.3% | $107.5M |